ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2010/04/02 | 258.8 | 260 | 255 | 259.5 | +2 | +0.8% | 126,400 |
| 2010/04/01 | 258.8 | 261.3 | 255.3 | 257.5 | -4.8 | -1.8% | 177,600 |
| 2010/03/31 | 264.8 | 267 | 259.5 | 262.3 | -5 | -1.9% | 174,000 |
| 2010/03/30 | 258.8 | 270.8 | 257.5 | 267.3 | +6.5 | +2.5% | 154,400 |
| 2010/03/29 | 251.5 | 261.8 | 249.5 | 260.8 | +8.3 | +3.3% | 150,000 |
| 2010/03/26 | 254 | 257 | 252.5 | 252.5 | -1.5 | -0.6% | 123,200 |
| 2010/03/25 | 257.8 | 259.5 | 254 | 254 | -6.5 | -2.5% | 148,800 |
| 2010/03/24 | 267 | 267 | 260.3 | 260.5 | -3.3 | -1.3% | 127,200 |
| 2010/03/23 | 256.5 | 263.8 | 254.5 | 263.8 | +4 | +1.5% | 202,000 |
| 2010/03/19 | 260.8 | 264 | 253.3 | 259.8 | -2.7 | -1% | 172,000 |
| 2010/03/18 | 265 | 268.8 | 260.5 | 262.5 | -0.3 | -0.1% | 164,400 |
| 2010/03/17 | 252.5 | 263.8 | 251.8 | 262.8 | +9.5 | +3.8% | 194,000 |
| 2010/03/16 | 257.5 | 257.5 | 252.5 | 253.3 | -6.5 | -2.5% | 256,000 |
| 2010/03/15 | 263 | 266 | 258.8 | 259.8 | -7.7 | -2.9% | 214,000 |
| 2010/03/12 | 264 | 270.5 | 264 | 267.5 | +0.2 | +0.1% | 104,000 |
| 2010/03/11 | 259.8 | 270.3 | 259 | 267.3 | +6.3 | +2.4% | 229,600 |
| 2010/03/10 | 267.5 | 271.3 | 257 | 261 | -8.5 | -3.2% | 482,800 |
| 2010/03/09 | 278.8 | 279.3 | 263.3 | 269.5 | -10 | -3.6% | 456,400 |
| 2010/03/08 | 280.8 | 284 | 277.8 | 279.5 | -1.3 | -0.5% | 234,800 |
| 2010/03/05 | 280.8 | 284.3 | 279.5 | 280.8 | -3.7 | -1.3% | 182,000 |
| 2010/03/04 | 285 | 288 | 282.5 | 284.5 | -3 | -1% | 112,800 |
| 2010/03/03 | 281.3 | 289.8 | 276 | 287.5 | +6.2 | +2.2% | 361,200 |
| 2010/03/02 | 289.5 | 289.5 | 280.3 | 281.3 | -7 | -2.4% | 201,600 |
| 2010/03/01 | 289.3 | 294.8 | 285 | 288.3 | -4.2 | -1.4% | 231,600 |
| 2010/02/26 | 293.8 | 299.3 | 289.5 | 292.5 | +0.2 | +0.1% | 124,000 |
| 2010/02/25 | 298.8 | 306.5 | 290.3 | 292.3 | -8 | -2.7% | 400,800 |
| 2010/02/24 | 300 | 305 | 296.5 | 300.3 | +4 | +1.3% | 366,400 |
| 2010/02/23 | 292.5 | 300 | 278.3 | 296.3 | +5.8 | +2% | 404,400 |
| 2010/02/22 | 300 | 306.3 | 290.5 | 290.5 | -4.8 | -1.6% | 266,400 |
| 2010/02/19 | 297.5 | 309 | 295.3 | 295.3 | ±0 | ±0% | 292,000 |
| 2010/02/18 | 305 | 307.5 | 293.8 | 295.3 | -13.2 | -4.3% | 415,200 |
| 2010/02/17 | 311.3 | 315 | 302.8 | 308.5 | -8.8 | -2.8% | 622,400 |
| 2010/02/16 | 294.8 | 329.5 | 292.5 | 317.3 | +27.8 | +9.6% | 1,133,600 |
| 2010/02/15 | 272.5 | 290 | 270.8 | 289.5 | +10.5 | +3.8% | 730,400 |
| 2010/02/12 | 262.5 | 281.3 | 257.8 | 279 | +17.7 | +6.8% | 710,400 |
| 2010/02/10 | 254 | 261.3 | 251.3 | 261.3 | +14.8 | +6% | 350,000 |
| 2010/02/09 | 246.8 | 250 | 245.3 | 246.5 | -4.3 | -1.7% | 196,000 |
| 2010/02/08 | 252 | 256.8 | 249.5 | 250.8 | -6.2 | -2.4% | 223,600 |
| 2010/02/05 | 260 | 264 | 251.8 | 257 | -7 | -2.7% | 392,000 |
| 2010/02/04 | 251 | 272 | 250.8 | 264 | +11.5 | +4.6% | 679,200 |
| 2010/02/03 | 250 | 256.5 | 246.8 | 252.5 | -2.5 | -1% | 240,400 |
| 2010/02/02 | 260 | 260 | 250 | 255 | -1.8 | -0.7% | 312,400 |
| 2010/02/01 | 240.3 | 259.8 | 240 | 256.8 | +24 | +10.3% | 916,000 |
| 2010/01/29 | 227.5 | 242 | 226.5 | 232.8 | +1.8 | +0.8% | 203,600 |
| 2010/01/28 | 234.5 | 234.5 | 228.8 | 231 | -3.5 | -1.5% | 158,800 |
| 2010/01/27 | 234 | 243.8 | 231.8 | 234.5 | +1.7 | +0.7% | 176,800 |
| 2010/01/26 | 246.3 | 249 | 232.8 | 232.8 | -13.5 | -5.5% | 209,600 |
| 2010/01/25 | 249.8 | 252 | 245.8 | 246.3 | -5.7 | -2.3% | 186,400 |
| 2010/01/22 | 239.8 | 253.5 | 238.3 | 252 | +8.5 | +3.5% | 269,600 |
| 2010/01/21 | 238.8 | 248 | 236.3 | 243.5 | +1 | +0.4% | 194,800 |
3551～
3600
件表示中 / 4943件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 127,300円 | +197.7% | - | 0.00% | 52.02倍 | 1.66倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 持田薬 | 348,000円 | +3.0% | +27.5% | 2.30% | 22.03倍 | 0.96倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ゼリア新薬 | 232,400円 | +9.6% | +17.5% | 1.98% | 13.13倍 | 1.29倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 鳥居薬 | 392,500円 | +11.1% | +20.6% | 3.06% | 22.99倍 | 0.92倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 杏林製薬 | 153,000円 | +3.2% | +4.5% | 3.40% | 17.58倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
